selected publications
-
HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers.
Cancer discovery.
2020
Academic Article
GET IT
Times cited: 252 -
Optimizing immunotherapy for gynecologic cancers.
Current opinion in obstetrics & gynecology.
2020
Information Resource
GET IT
Times cited: 24 -
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
Cancer.
2019
Academic Article
GET IT
Times cited: 56 -
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.
International journal of cancer.
2019
Academic Article
GET IT
Times cited: 42 -
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
Gynecologic oncology.
2019
Academic Article
GET IT
Times cited: 55 -
A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2018
Academic Article
GET IT
Times cited: 8 -
Myocarditis with tremelimumab plus durvalumab combination therapy for endometrial cancer: A case report.
2018
GET IT
Times cited: 26 - New therapies for advanced, recurrent, and metastatic endometrial cancers. Gynecologic oncology research and practice. 2017 Information Resource GET IT
-
A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.
Investigational new drugs.
2017
Academic Article
GET IT
Times cited: 14 -
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study).
Cancer.
2016
Academic Article
GET IT
Times cited: 75 -
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Gynecologic oncology.
2016
Academic Article
GET IT
Times cited: 21 - Nonbacterial thrombotic endocarditis with embolic cerebral vascular accidents in a patient with advanced, recurrent clear cell carcinoma of the ovary: A case report. 2016 GET IT
-
An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2016
Academic Article
GET IT
Times cited: 19 -
Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N.
Gynecologic oncology.
2015
Academic Article
GET IT
Times cited: 35 -
Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma.
Gynecologic oncology.
2014
Academic Article
GET IT
Times cited: 19 -
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
Gynecologic oncology.
2014
Academic Article
GET IT
Times cited: 106 -
Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2013
Academic Article
GET IT
Times cited: 2 -
Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2013
Academic Article
GET IT
Times cited: 42 -
Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival.
Radiation oncology (London, England).
2013
Academic Article
GET IT
Times cited: 20 -
Placental site trophoblastic tumor: analysis of presentation, treatment, and outcome.
Gynecologic oncology.
2012
Academic Article
GET IT
Times cited: 48